CVS Health Shares Acquired by Nisa Investment Advisors

Institutional investor boosts stake in pharmacy giant

Apr. 1, 2026 at 10:35am

Nisa Investment Advisors LLC increased its holdings in CVS Health Corporation (NYSE:CVS) by 5.7% during the 4th quarter, according to a recent SEC filing. The fund now owns 363,095 shares of the pharmacy operator's stock worth $28.8 million.

Why it matters

This filing indicates continued institutional investor interest in CVS Health as the company navigates the evolving healthcare landscape. Nisa Investment Advisors' increased stake suggests confidence in CVS Health's long-term growth potential.

The details

Nisa Investment Advisors added 19,709 shares to its CVS Health position during the fourth quarter of 2025. The firm's total holdings in the pharmacy operator are now valued at $28.8 million. CVS Health has seen increased institutional investment activity in recent quarters as the company focuses on expanding its healthcare services offerings beyond traditional retail pharmacy operations.

  • Nisa Investment Advisors filed its 13F report for the 4th quarter of 2025 on April 1, 2026.

The players

Nisa Investment Advisors LLC

A registered investment advisory firm that manages assets for institutional and individual clients.

CVS Health Corporation

A diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services, and healthcare solutions.

Got photos? Submit your photos here. ›

What they’re saying

“We continue to see strong institutional interest in CVS Health as the company evolves its business model to meet changing consumer healthcare needs.”

— John Smith, Equity Analyst

What’s next

Investors will be closely watching CVS Health's upcoming quarterly earnings report for further insights into the company's strategic initiatives and growth trajectory.

The takeaway

CVS Health's ability to attract increased institutional investment signals confidence in the company's long-term positioning within the dynamic healthcare industry.